ETFs & Funds
up 8% after pricing of offering -
- Make that 10.5%
Add a reply...
Latest StockTalks »
people get EXEL breaking news and analysis by email alert.
Get email alerts on EXEL »
Get latest price
From other sites
Exelixis' Kidney Cancer Drug Cabometyx Positive in Phase II
at Zacks.com (Tue, 5:15PM)
Exelixis (EXEL) Worth a Look: Stock Up 8.1% in Session
at Zacks.com (May 16, 2016)
Exelixis (EXEL) Reports Wider-than-Expected Loss in Q1
at Zacks.com (May 5, 2016)
Exelixis (EXEL): What's Ahead for the Stock in Q1 Earnings?
at Zacks.com (May 2, 2016)
Commit To Purchase Exelixis At $3.50, Earn 22.3% Annualized Using Options
at Nasdaq.com (Apr 14, 2016)